(QMOM) Alpha Architect U.S. - Overview
Etf: Momentum Stocks, Us Equities, Quantitative Strategy
Dividends
| Dividend Yield | 0.53% |
| Yield on Cost 5y | 0.56% |
| Yield CAGR 5y | 53.96% |
| Payout Consistency | 62.6% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.9% |
| Relative Tail Risk | 5.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.15 |
| Alpha | -12.76 |
| Character TTM | |
|---|---|
| Beta | 1.072 |
| Beta Downside | 1.151 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.46% |
| CAGR/Max DD | 0.62 |
Description: QMOM Alpha Architect U.S. December 29, 2025
The Alpha Architect U.S. Quantitative Momentum ETF (BATS: QMOM) is designed to allocate at least 80% of its net assets-plus any investment-purpose borrowings-to U.S.-listed equities that satisfy the Sub-Adviser’s quantitative definition of momentum. Using a multi-step, rules-based model, the Sub-Adviser screens the market for roughly 50-200 stocks exhibiting the strongest relative price-momentum, concentrating the portfolio in those securities.
Key metrics (as of the most recent filing) show an expense ratio of 0.35%, a 12-month turnover of about 55%, and an average market-cap weighting near $5 billion, placing the fund squarely in the mid-cap growth space. Recent back-tests suggest a Sharpe ratio of ~0.85 versus the Russell 2000, and the strategy’s performance tends to be positively correlated with a steepening yield-curve, which often signals a favorable environment for growth-oriented momentum stocks.
For a deeper, data-driven comparison of QMOM’s factor exposures and valuation characteristics, you might find the free analytics on ValueRay worth a quick look.
What is the price of QMOM shares?
Over the past week, the price has changed by +3.91%, over one month by +4.44%, over three months by +7.54% and over the past year by +4.28%.
Is QMOM a buy, sell or hold?
What are the forecasts/targets for the QMOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 78.1 | 9.8% |
QMOM Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 369.1m USD (369.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 369.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 369.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.87% (E(369.1m)/V(369.1m) * Re(9.87%) + (debt-free company))
Discount Rate = 9.87% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)